AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has served up a third phase 3 win this year, offering further evidence the…

President Donald Trump has ordered the FDA to perform priority reviews of psychedelic drugs as part of a push to clear…

In another sign that the biotech IPO market is heating back up, Odyssey Therapeutics has made a fresh announcement of…

In the relentless pursuit of sustainable energy solutions, solar hydrogen production has emerged as a beacon of hope, promising a…

In a groundbreaking study set to reshape our understanding of longevity, researchers Sarikaya Demirbas and Naharci have unveiled pivotal mortality…

In a groundbreaking advancement in clinical infection control, a comprehensive multi-center randomized controlled trial presented at ESCMID Global 2026 has…

A groundbreaking study unveiled at ESCMID Global 2026 in Munich has revealed that antiretroviral therapy (ART) has a profound impact…

In recent years, the growing population of older adults has placed cardiovascular health at the forefront of clinical research, especially…

In a groundbreaking study poised to revolutionize our understanding of premature ovarian failure (POF), researchers have unveiled a novel molecular…

In the evolving landscape of healthcare, the care of frail elderly patients within orthopaedic settings emerges as a critical frontier…